In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 7, 2000, Pages 1803-1811

  Kezuka, Takeshi ^a   Streilein, J Wayne ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTERIOR EYE CHAMBER; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CELL SPECIFICITY; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNE DEFICIENCY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ANTERIOR CHAMBER; ANTIGEN-PRESENTING CELLS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HYPERSENSITIVITY, DELAYED; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN; PERITONEAL CAVITY; T-LYMPHOCYTES, CYTOTOXIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034122206     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Streilein JW. Immune regulation and the eye: a dangerous compromise. FASEB J. 1987;1:199-208.
2. Niederkorn JY. Immune privilege and immune regulation in the eye. Adv Immunol. 1990;48:191-226.
3. Streilein JW. Molecular basis of ACAID. Ocular Immunol Inflamm. 1997;5:517-518.
4. Streilein JW, Ksander BR, Taylor AW. Immune deviation in relation to ocular immune privilege. J Immunol. 1997;158:3557-3560.
5. Wilbanks GA, Streilein JW. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen: evidence of two functionally and phenotypically distinct T-suppressor cell populations. Immunology. 1990; 71:383-389.
6. Wilbanks GA, Mammolenti M, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID), III: induction of ACAID depends upon intraocular transforming growth factor-beta. Eur J Immunol. 1992;22:165-173.
7. Kezuka T, Streilein JW. Analysis of in vivo regulatory properties of T cells activated in vitro by TGF-β2-treated antigen presenting cells. Invest Ophthalmol Vis Sci. In press.
8. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell. 1994;76:17-28.
9. Taylor AW, Alard P, Yee DG, Streilein JW. Aqueous humor induces transforming growth factor-beta (TGF-beta)-producing regulatory T-cells. Curr Eye Res. 1997;16:900-908.
10. Takeuchi M, Kosiewicz MM, Alard P, Streilein JW. On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation. Eur J Immunol. 1997;27:1648-1656.
11. Moore MW, Carbone FR, Bevan MJ. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell. 1988;54:777-789.
12. Williamson JS, Streilein JW. Impaired induction of delayed hypersensitivity following anterior chamber inoculation of alloantigens. Reg Immunol. 1988;1:15-23.
13. Streilein JW. Peripheral tolerance induction: lessons from immune privileged sites and tissues. Transplant Proc. 1996;28:2066-2070.
14. Streilein JW, Takeuchi M, Taylor AW. Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity. Hum Immunol. 1997;52:138-143.
15. Kosiewicz MM, Okamoto S, Miki S, Ksander BR, Shimizu T, Streilein JW. Imposing deviant immunity on the presensitized state. J Immunol. 1994;153:2962-2973.
16. Kosiewicz MM, Streilein JW. Intraocular injection of class II-restricted peptide induces an unexpected population of CDS regulatory cells. J Immunol. 1996;157:1905-1912.
17. Kosiewicz MM, Alard P, Streilein JW. Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment in IFN-gamma and induction of TGF-beta and IL-4 production. J Immunol. 1998;161:5382-5390.
18. D'Orazio TJ, Niederkorn JY. A novel role for TGF-beta and IL-10 in the induction of immune privilege. J Immunol. 1998;160:2089-2098.
19. D'Orazio TJ, Niederkorn JY. The nature of antigen in the eye has a profound effect on the cytokine milieu and resultant immune response. Eur J Immunol. 1998;28:1544-1553.
20. Li XY, D'Orazio LT, Niederkorn JY. Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Immunology. 1996;89:34-45.
21. Wilbanks GA, Streilein JW. Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties. Reg Immunol. 1992;4:130-137.
22. Wilbanks GA, Streilein JW. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. Eur J Immunol. 1992;22:1031-1036.
23. Hara Y, Caspi RR, Wiggert B, Dorf M, Streilein JW. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye [published erratum appears in J Immunol. 1992; 149(12):4116]. J Immunol. 1992;149:1531-1538.
24. Hara Y, Okamoto S, Rouse B, Streilein JW. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type. J Immunol. 1993;151:5162-5171.
25. Kurts C, Heath WR, Carbone FR, Allison J, Miller JF, Kosaka H. Constitutive class 1-restricted exogenous presentation of self antigens in vivo. J Exp Med. 1996;184:923-930.
26. Takeuchi M, Alard P, Streilein JW. TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells. J Immunol. 1998;160:1589-1597.